Comparison between Saroja Pharma IPO and Unihealth Consultancy IPO.
IPO Details
Saroja Pharma IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Unihealth Consultancy IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Saroja Pharma IPO is up to ₹8.66 Cr whereas the issue size of the Unihealth Consultancy IPO is up to ₹53.70 Cr. The final issue price of Saroja Pharma IPO is ₹84.00 per share and of Unihealth Consultancy IPO is ₹132.00 per share.
Saroja Pharma IPO opens on Aug 31, 2023, while Unihealth Consultancy IPO opens on Sep 08, 2023. The closing date of Saroja Pharma IPO and Unihealth Consultancy IPO is Sep 05, 2023, and Sep 12, 2023, respectively.
In the Saroja Pharma IPO Retail Individual Investors (RII) are offered 5,15,200 shares while in Unihealth Consultancy IPO retail investors are offered 5,15,200 shares. Qualified Institutional Buyers (QIB) are offered in Saroja Pharma IPO and 8,15,000 shares in Unihealth Consultancy IPO.